Abstract
Alopecia after irradiation was elegantly presented in a recent article (1). Note was made that radioprotectors—for example, WR-2721—showed efficacy in animal models (2, 3). The authors comment that they await Phase I-II trials in humans. These trials actually have been done at the University of Pennsylvania and were successful (S. Hahn, E. Glatstein, personal communication), and are now being tested at the University of Arizona as well. If we do not bring radiobiology quickly up to the level of technology, then, as one famed National Cancer Institute director once said, the linear accelerator will someday be put in the Smithsonian.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callMore From: International Journal of Radiation Oncology*Biology*Physics
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
